![CytoDyn Inc (QB)](/common/images/company/NO_CYDY.png)
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0037 | 2.67727930535 | 0.1382 | 0.147 | 0.1382 | 1248476 | 0.14138579 | CS |
4 | -0.008 | -5.33689126084 | 0.1499 | 0.174 | 0.131243 | 1875835 | 0.1409571 | CS |
12 | 0.0019 | 1.35714285714 | 0.14 | 0.315 | 0.1275 | 2717367 | 0.16819314 | CS |
26 | -0.0206 | -12.6769230769 | 0.1625 | 0.315 | 0.1275 | 2616005 | 0.17393853 | CS |
52 | -0.0831 | -36.9333333333 | 0.225 | 0.418 | 0.1275 | 2343982 | 0.1878363 | CS |
156 | -1.5381 | -91.5535714286 | 1.68 | 2.54 | 0.1275 | 2191788 | 0.50915436 | CS |
260 | -0.2832 | -66.6196189132 | 0.4251 | 10.01 | 0.1275 | 2979604 | 2.09983204 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.